TAVI patients with bystander coronary artery disease should receive PCI: pros and cons.
作者信息
Rodés-Cabau Josep, Avvedimento Marisa, McDonaugh Benedict, Patterson Tiffany
机构信息
Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
Hospital Clínic Barcelona, Barcelona, Spain.
出版信息
EuroIntervention. 2024 Nov 18;20(22):1366-1369. doi: 10.4244/EIJ-E-24-00054.
Abstract
摘要
相似文献
1
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons.患有无症状性冠状动脉疾病的经导管主动脉瓣置入术（TAVI）患者应接受经皮冠状动脉介入治疗（PCI）：利弊分析
EuroIntervention. 2024 Nov 18;20(22):1366-1369. doi: 10.4244/EIJ-E-24-00054.
2
Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis.经 TAVI 治疗的主动脉瓣狭窄患者行 PCI 策略的对比分析：系统评价和网络荟萃分析。
Clin Cardiol. 2024 Aug;47(8):e24324. doi: 10.1002/clc.24324.
3
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄患者：系统评价与荟萃分析
Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.
4
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons.经导管主动脉瓣置入术（TAVI）前应进行旁观者冠状动脉病变的经皮冠状动脉介入治疗（PCI）：利弊分析
EuroIntervention. 2022 Nov 18;18(10):783-785. doi: 10.4244/EIJ-E-22-00038.
5
Outcomes and Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with and Without Coronary Artery Disease.有或无冠状动脉疾病患者经导管与外科主动脉瓣置换术的疗效及成本效益
J Cardiovasc Dev Dis. 2025 Jun 7;12(6):217. doi: 10.3390/jcdd12060217.
6
Coronary artery disease and TAVI: Current evidence on a recurrent issue.冠状动脉疾病与经导管主动脉瓣置换术：一个反复出现的问题的最新证据。
Catheter Cardiovasc Interv. 2023 May;101(6):1154-1160. doi: 10.1002/ccd.30653. Epub 2023 Mar 30.
7
Management of Coronary Artery Disease in the Context of Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis of Percutaneous Coronary Intervention Timing and an Algorithmic Approach to Management.经导管主动脉瓣植入术背景下的冠状动脉疾病管理：经皮冠状动脉介入治疗时机的系统评价和荟萃分析以及管理的算法方法
Interv Cardiol. 2025 Jun 19;20:e21. doi: 10.15420/icr.2024.51. eCollection 2025.
8
Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†.经导管主动脉瓣植入术联合择期冠状动脉支架置入术：一种同步治疗方法†
Eur J Cardiothorac Surg. 2015 Jun;47(6):1083-9. doi: 10.1093/ejcts/ezu339. Epub 2014 Sep 12.
9
Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.主动脉瓣和冠状动脉疾病患者行经皮（TAVI+PCI）和外科联合治疗（SAVR+CABG）的趋势和结果：国家再入院数据库（NRD）分析。
Catheter Cardiovasc Interv. 2023 Nov;102(5):946-957. doi: 10.1002/ccd.30832. Epub 2023 Sep 12.
10
Evaluation and management of coronary artery disease in transcatheter aortic valve implantation candidates with severe aortic stenosis and coronary artery disease: technology and techniques.经导管主动脉瓣植入术候选患者严重主动脉瓣狭窄合并冠状动脉疾病的评估与管理：技术与技巧。
Expert Rev Med Devices. 2024 Oct;21(10):915-925. doi: 10.1080/17434440.2024.2401492. Epub 2024 Sep 13.
本文引用的文献
1
Invasive Treatment Strategy for Older Patients with Myocardial Infarction.老年心肌梗死患者的侵入性治疗策略。
N Engl J Med. 2024 Nov 7;391(18):1673-1684. doi: 10.1056/NEJMoa2407791. Epub 2024 Sep 1.
2
PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.经导管主动脉瓣植入术患者的经皮冠状动脉介入治疗
N Engl J Med. 2024 Dec 12;391(23):2189-2200. doi: 10.1056/NEJMoa2401513. Epub 2024 Aug 31.
3
Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR-When and How?主动脉瓣狭窄伴冠状动脉疾病：SAVR 还是 TAVR-何时以及如何选择？
Can J Cardiol. 2024 Feb;40(2):218-234. doi: 10.1016/j.cjca.2023.09.023. Epub 2023 Sep 26.
4
Transcatheter heart valve commissural alignment: an updated review.经导管心脏瓣膜连合对齐：最新综述
Front Cardiovasc Med. 2023 Apr 19;10:1154556. doi: 10.3389/fcvm.2023.1154556. eCollection 2023.
5
Angina in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术治疗的重度主动脉瓣狭窄患者的心绞痛。
Rev Esp Cardiol (Engl Ed). 2023 Dec;76(12):991-1002. doi: 10.1016/j.rec.2023.04.004. Epub 2023 May 1.
6
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.经皮冠状动脉介入治疗在前瞻性经导管主动脉瓣植入术之前的作用：一项随机临床试验。
JACC Cardiovasc Interv. 2021 Sep 27;14(18):1965-1974. doi: 10.1016/j.jcin.2021.06.041.
7
Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR.经 TAVR 术前评估行经皮冠状动脉介入治疗的操作特点和晚期结果。
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2601-2613. doi: 10.1016/j.jcin.2020.07.009. Epub 2020 Oct 14.
8
Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.冠状动脉疾病与经导管主动脉瓣置换术：JACC 最新技术评论。
J Am Coll Cardiol. 2019 Jul 23;74(3):362-372. doi: 10.1016/j.jacc.2019.06.012.
Zotero 插件